Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2025-03-28 | Ms. Lurker holds a B.S. in Biology from Seattle Pacific University and an M.B.A. from the University of Evansville. |
| Filing Date | Source Excerpt |
|---|---|
| 2016-10-26 | Ms. Lurker received a B.S. in Biology from Seattle Pacific University and an M.B.A. from the University of Evansville. Ms. Lurker’s role as President and Chief Executive Officer of the Company, as well as her broad ranging experience in the pharmaceutical industry and her track record of maximizing the potential of new therapies and successfully implementing innovative U.S. and global drug launches, provide her with valuable expertise and perspective on the Company and its corporate strategy, management, operations and governance. |
| 2017-05-15 | Ms. Lurker joined us as President and Chief Executive Officer and was appointed to serve as a director of our Board on September 15, 2016. |
| 2017-11-13 | Ms. Lurker received a B.S. in Biology from Seattle Pacific University and an M.B.A. from the University of Evansville. |
| 2018-05-11 | Nancy Lurker 408,366 * |
| 2019-04-29 | Ms. Lurker received a B.S. in Biology from Seattle Pacific University and an M.B.A. from the University of Evansville. |
| 2020-04-28 | Ms. Lurker received a B.S. in Biology from Seattle Pacific University and an M.B.A. from the University of Evansville. |
| 2020-10-16 | Nancy Lurker 2,781,592 2.05 % |
| 2021-05-03 | Ms. Lurker received a B.S. in Biology from Seattle Pacific University and an M.B.A. from the University of Evansville. |
| 2022-04-28 | Ms. Lurker received a B.S. in Biology from Seattle Pacific University and an M.B.A. from the University of Evansville. We believe Ms. Lurker is qualified to serve on our Board because of her role as our President and Chief Executive Officer, as well as her broad ranging experience in the pharmaceutical industry and her track record of maximizing the potential of new therapies with over ten years of clinical drug development at BMS, Pharmacia, and Novartis in her capacity as a senior executive. |
| 2023-04-28 | Ms. Lurker received a B.S. in Biology from Seattle Pacific University and an M.B.A. from the University of Evansville. |
| 2024-04-26 | Ms. Lurker holds a B.S. in Biology from Seattle Pacific University and an M.B.A. from the University of Evansville. We believe Ms. Lurker is qualified to serve on our Board because of her broad ranging experience in the pharmaceutical industry and her track record of maximizing the potential of new therapies. |
| Filing Date | Source Excerpt |
|---|---|
| 2009-04-24 | Nancy Lurker, age 51. Ms. Lurker joined us as Chief Executive Officer and a director in November 2008. |
| 2010-04-30 | Nancy Lurker, age 52. Ms. Lurker joined us as Chief Executive Officer and a director in November 2008. ... Information regarding Ms. Lurker’s compensation can be found elsewhere in this Proxy Statement under the caption “Executive Compensation.” ... Nancy Lurker CEO (1) 2009 $ 550,000 $ 192,500 - - - - $ 21,180 $ 763,680 |
| 2011-04-28 | Nancy Lurker, age 53. Ms. Lurker joined us as Chief Executive Officer and a director in November 2008. ... Information regarding Ms. Lurker’s compensation can be found in this Proxy Statement under the caption “Executive Compensation.” ... Nancy Lurker CEO 2010 $ 550,000 $ 512,500 $ 319,997 $ 169,638 - $ 33,258 $ 1,585,393 |
| 2012-04-27 | Nancy Lurker joined us as Chief Executive Officer and a director in November 2008. ... Ms. Lurker has held senior leadership roles in pharmaceutical companies and services companies serving the pharmaceutical industry, and has specific skills in strategy, sales and operations. ... Information regarding Ms. Lurker's compensation can be found in this Proxy Statement under the caption “Executive Compensation.” ... The following table sets forth certain information concerning compensation paid to our Chief Executive Officer ... Nancy Lurker - CEO ... 2011 ... Total ... $1,377,037. |
| 2013-04-30 | Nancy Lurker joined as Chief Executive Officer and director in November 2008. Her total compensation for 2012 was $1,218,895 as detailed in the Summary Compensation Table. |
Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-22